This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Shanghai Hyamab Biotech Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dongxu Wang: Innovator in Antibody Development
Introduction
Dongxu Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work is characterized by a commitment to advancing medical science and improving therapeutic options.
Latest Patents
Dongxu Wang holds a patent for the "NKG2A Antibody, Preparation Method Therefor and Application Thereof." This innovative patent reflects his expertise in antibody development and its potential applications in treating various diseases.
Career Highlights
Wang is currently employed at Shanghai Hyamab Biotech Co., Ltd., where he continues to push the boundaries of biotechnological research. His role at the company allows him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Qing Duan and Lile Liu. Their collective efforts contribute to the innovative environment at Shanghai Hyamab Biotech Co., Ltd.
Conclusion
Dongxu Wang is a key figure in the biotechnology sector, with a focus on antibody development. His contributions are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile